Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Masaki, Kakimoto"'
Autor:
Hiroki Kitagawa, Toshihito Nomura, Yuki Kaiki, Masaki Kakimoto, Tanuza Nazmul, Keitaro Omori, Norifumi Shigemoto, Takemasa Sakaguchi, Hiroki Ohge
Publikováno v:
International Journal of Infectious Diseases, Vol 126, Iss , Pp 73-78 (2023)
Objectives: This study assessed the concentration of SARS-CoV-2 in the air of hospital rooms occupied by patients with COVID-19 who had viable SARS-CoV-2 in nasopharyngeal (NP) samples in early infection. Methods: Between July and October 2021, NP sw
Externí odkaz:
https://doaj.org/article/499f9ee7a1584cb8be6b80a1e03e9cae
Autor:
Masaki Kakimoto, Toshihito Nomura, Tanuza Nazmul, Hiroki Kitagawa, Keishi Kanno, Keiko Ogawa-Ochiai, Hiroki Ohge, Masanori Ito, Takemasa Sakaguchi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Several traditional Japanese Kampo formulas are known to have inhibitory effects on infections with viruses that cause respiratory symptoms. Although some herbs and their components have been reported to suppress SARS-CoV-2 replication in vitro, it i
Externí odkaz:
https://doaj.org/article/b479fa02143d4b9382bbc796b0621716
Autor:
Masaki Kakimoto, Daisuke Miyamori, Keitaro Omori, Tomoki Kobayashi, Kotaro Ikeda, Seiya Kashiyama, Hiroki Ohge, Masanori Ito
Publikováno v:
Journal of Infection. 86:147-153
During the coronavirus disease 2019 (COVID-19) pandemic, a change in the trend of infections was observed. However, there are few reports comprehensively assessing the impact of the early phase of COVID-19 on the trend of bacteria isolated.We extract
Publikováno v:
Fisheries Science. 89:243-251
Autor:
Yayoiko Ito, Takahiro Kametani, Tomohiko Sakuda, Daisuke Miyamori, Akihiro Kawahara, Tadahiko Kubo, Nobusuke Kishikawa, Toshikazu Ohigashi, Masaki Kakimoto, Daisuke Furuta, Yuka Kikuchi, Keishi Kanno, Tomoki Kobayashi, Yuichiro Otani, Yuya Shigenobu, Masanori Ito
Publikováno v:
Internal Medicine
We herein report a case of aortitis induced by granulocyte colony-stimulating factor (G-CSF) that coincided with lung injury, splenomegaly, and cutaneous manifestations during treatment for recurrent extraosseous mucinous chondrosarcoma. Computed tom
Autor:
Hiroki Kitagawa, Toshihito Nomura, Yuki Kaiki, Masaki Kakimoto, Tanuza Nazmul, Keitaro Omori, Norifumi Shigemoto, Takemasa Sakaguchi, Hiroki Ohge
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 126
This study assessed the concentration of SARS-CoV-2 in the air of hospital rooms occupied by patients with COVID-19 who had viable SARS-CoV-2 in nasopharyngeal (NP) samples in early infection.Between July and October 2021, NP swabs were collected fro
Autor:
Mutsumi Miyauchi, Nobusuke Kishikawa, Quoc Thang Pham, Yuka Kikuchi, Masaki Kakimoto, Phuong Thao Nguyen, Susumu Tazuma, Keishi Kanno, Masanori Ito, Tomoki Kobayashi, Yuichiro Otani, Koji Arihiro
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:3255-3268
Deoxycholic acid (DCA), a secondary bile acid, is reportedly increased in the serum of patients with nonalcoholic steatohepatitis and animals with experimentally induced hepatocellular carcinoma (HCC), but its contribution to malignant behaviors of H
Autor:
Takahiro Kametani, Yayoiko Ito, Tomoki Kobayashi, Daisuke Miyamori, Yuichiro Otani, Hiromasa Tanabe, Nobusuke Kishikawa, Masanori Ito, Yuka Kikuchi, Yuya Shigenobu, Masaki Kakimoto, Akihiro Kawahara, Keishi Kanno
Publikováno v:
Internal Medicine
We herein report on two male patients (age, 22 and 44 years) who were referred to our department with swelling of the upper right arm after attending other hospitals. Right subclavian vein thrombosis was demonstrated by ultrasonography and they were
Autor:
Toshihito Nomura, Hiroki Kitagawa, Masaki Kakimoto, Yuki Kaiki, Tanuza Nazmul, Daisuke Miyamori, Keitaro Omori, Norifumi Shigemoto, Masanori Ito, Takemasa Sakaguchi, Hiroki Ohge
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 28(7)
New treatment methods, such as REGN-CoV2, have been approved for patients with coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the effect of the drug on the duration of infectious viral
Autor:
Hiroki Kitagawa, Norifumi Shigemoto, Nobuaki Shime, Hiroki Ohge, Keitaro Omori, Takemasa Sakaguchi, Toshihito Nomura, Tanuza Nazmul, Masaki Kakimoto
Publikováno v:
Journal of Infection and Chemotherapy
Background: Around 5% of patients with coronavirus disease ( COVID-19) caused by severe acute respiratory syndrome coronavirus 2 develop severe COVID-19. Severe COVID-19 requires respiratory management with mechanical ventilation and an extended peri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8c76d86661c9678975032629318a77
https://doi.org/10.21203/rs.3.rs-395009/v1
https://doi.org/10.21203/rs.3.rs-395009/v1